NORMAN, OK – In a significant breakthrough that could redefine future cancer treatments, researchers at the University...
ROCKVILLE, MD – [Insert Date] – MacroGenics, Inc., a biopharmaceutical company dedicated to developing innovative cancer therapies,...
By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation In recent years, Glucagon-Like Peptide-1 (GLP-1) receptor...
NEW YORK, NY — As the world enters the second week of October, a month traditionally dominated...
NEW YORK, NY — In a move that has sent shockwaves of optimism through the global scientific...
To the average observer, breast cancer is often viewed through a strictly feminine lens. The ubiquitous pink...
Introduction The relationship between the United States and the World Health Organization (WHO) has long served as...
The marriage of artificial intelligence and pharmaceutical research has long been promised as a panacea for the...
In a landmark development for digital health, San Francisco-based Sirona Medical has successfully closed a $40 million...
In a significant move to modernize its approach to orphan drug development, the U.S. Food and Drug...
